Tirzepatide works by activating two hormone receptorsGLP-1 and GIPthat reduce hunger and stabilize blood sugar, creating conditions for sustainable weight loss
Oral formulations of these compounds typically have shorter half-lives due to first-pass hepatic metabolism, requiring more frequent dosing schedules for comparable clinical effect
For example, the partitioning of arginine metabolism (the iNOS/Arg1 axis) or alterations in the Trp-Kyn pathway observed in various inflamed tissues often occur in parallel with M1/M2-like macrophage polarization states, and therefore may more likely serve as metabolic manifestations of inflammatory status and immune cell functional remodeling
Klonoff DC, Bassock S, Engels E, Frederiksen M, Marber M
503A Pharmacies The Problem Nobody Plans For GLP-1 injections helped you lose it
Robert Lustig to "Huberman Lab" for a critical examination of our understanding of calories and sugar